| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net (loss) earnings | 13,072 | 19,734 |
| Depreciation and amortization | 24,001 | 16,082 |
| Right-of-use asset reduction | 5,415 | 3,767 |
| Loss on sale of property and equipment | -124 | -29 |
| Equity-based compensation expense | 10,078 | 6,502 |
| Deferred income taxes | -4,462 | -6,485 |
| Inventory write-down | 2,415 | 2,045 |
| Inventories | 21,143 | 12,988 |
| Prepaid expenses and other assets | 199 | 460 |
| Accounts payable | 4,131 | 5,813 |
| Other liabilities | -7,693 | -6,339 |
| Net cash provided by (used in) operating activities | 25,739 | 27,700 |
| Proceeds from the settlement of net investment hedges | 0 | 0 |
| Payments for net investment hedge | 1,072 | 1,072 |
| Proceeds from acquisition working capital adjustment | 865 | 865 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Purchases of property and equipment | 11,028 | 7,830 |
| Net cash provided by (used in) investing activities | -11,235 | -8,037 |
| Repurchase of common stock | 27,507 | 27,507 |
| Borrowings on line of credit | 1,600 | 1,600 |
| Payments on line of credit | 24,600 | 24,600 |
| Payments related to tax withholding for net-share settled equity awards | 2,291 | 2,191 |
| Distributions to redeemable noncontrolling interest | 1,258 | 379 |
| Net cash provided by (used in) financing activities | -54,056 | -53,077 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 3,197 | 3,032 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -36,355 | -30,382 |
| Cash and cash equivalents at beginning of period | 184,508 | - |
| Cash and cash equivalents at end of period | 148,153 | - |
USANA HEALTH SCIENCES INC (USNA)
USANA HEALTH SCIENCES INC (USNA)